US 2019/0290609 A1 · PHARMACEUTICAL COMPOSITION COMPRISING PALMITOYLETHANOLAMIDE AND L-ACETYLCARNITINE

Abstract

It is the object of the present invention a pharmaceutical composition for use in humans or animals containing N-palmitoylethanolamide for the control of the inflammatory and/or neuropathic pain of various origin. In particular, the present invention relates to a pharmaceutical composition comprising palmitoylethanolamide (PEA and L-acetylcarnitine (LAC), optionally with in addition an antioxidant compound such as a polyphenol, alpha-lipoic acid, and L-acetylcysteine.

Claims10

Dependent claims

A pharmaceutical composition, comprising:

palmitoylethanolamide (PEA) and L-acetylcarnitine (LAC).

Dependencies are inferred from the claim text.

Facts

Application

16/436,143Filed 10 Jun 2019

Priority

IT MI2014A00045419 Mar 2014

Published

26 Sep 2019

Term ends

Not estimatedThe source records don’t support an estimate.

Classification9 codes

A61K 31/221
Of acyclic acids, e.g. pravastatin: with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
A61K 9/0024
Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in…
A61K 9/006
Mouth and digestive tract, i.e. intraoral and peroral administration: oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or…
A61K 9/1623
Organic compounds, e.g. phospholipids, fats: sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules

Family

Application14/658,369Continuation · filed 16 Mar 2015

Application15/603,566Continuation in part · filed 24 May 2017

Application16/436,143Continuation in part

Application15/603,566Continuation

US 10,441,559 B2Related patent

US 2015/0265568 A1Published application

US 2017/0252314 A1Published application

US 2019/0290609 A1This patent

From the US filing history. Foreign family members aren’t listed.

Abstract

Facts

Application

16/436,143Filed 10 Jun 2019

Priority

IT MI2014A00045419 Mar 2014

Published

26 Sep 2019

Term ends

Not estimatedThe source records don’t support an estimate.

Classification9 codes

A61K 31/221
Of acyclic acids, e.g. pravastatin: with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
A61K 9/0024
Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in…
A61K 9/006
Mouth and digestive tract, i.e. intraoral and peroral administration: oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or…
A61K 9/1623
Organic compounds, e.g. phospholipids, fats: sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules

Family

Application14/658,369Continuation · filed 16 Mar 2015

Application15/603,566Continuation in part · filed 24 May 2017

Application16/436,143Continuation in part

Application15/603,566Continuation

US 10,441,559 B2Related patent

US 2015/0265568 A1Published application

US 2017/0252314 A1Published application

US 2019/0290609 A1This patent

From the US filing history. Foreign family members aren’t listed.

Pharmaceutical composition comprising palmitoylethanolamide and l-acetylcarnitine

Life of this patent

Abstract

Claims10

Pharmaceutical composition comprising palmitoylethanolamide and l-acetylcarnitine

Life of this patent

Abstract

Claims10